Immunotherapy: unleashing immune system to attack cancer

submitted by: mdanderson
Cancer immunotherapy treats the immune system rather than the tumor. Jim Allison, Ph.D., professor in Immunology at MD Anderson Cancer Center, has developed an innovative approach that will open doors for treating all types of cancer. Padmanee Sharma, M.D., Ph.D., associate professor in Genitourinary Medical Oncology and Immunology, is lead scientist on immunotherapy clinical trials. Listen to Allison and Sharma discuss their collaboration on MD Anderson’s Moon Shots Program to develop...

Need for Greater Transparency in Enrollment in Drug Trials

submitted by: WentzMR

In an article appearing in the May 2013 issue of Mayo Clinic Proceedings, Dr. Mark A. Yarborough from the University of California, Davis, proposes the need to develop better disclosure, transparency, and measures of social value for persons recruited to participate in clinical research. Available at: http://tinyurl.com/d8appv7

T-Cell Lymphoma Clinic Trials

submitted by: mdanderson

Our mission is to improve the cure rate of patients with PTCL and reduce treatment-related toxicity by developing novel targeted therapy using rationally designed small molecules, antibodies and combination regimens of biologic agents.

For referrals, please contact ayounes@mdanderson.org or Amanda Copeland at ARCopeland@mdanderson.org.

Targeted Therapy Promising For Cancer Patients

submitted by: mdanderson

Casey Carleton, a patient with metastatic melanoma explains his experience and success on Phase 1 clinical trial. Customizing targeted therapies to each tumor's molecular characteristics, instead of a one-size-fits-all approach by tumor type, may be more effective for some types of cancer, according to research conducted by The University of Texas MD Anderson Cancer Center. http://bit.ly/khHJA7

Want to know what drugs are in a patient’s body? Doctors know not to ask the patient.

submitted by: Clare Hovan

How does a doctor determine whether a drug will work if he doesn’t know what other drugs the patient is taking? This perplexing question challenged Dominion Diagnostics, a laboratory specializing in urine drug testing and medication monitoring. Without knowing exactly what the medications are, the number of possible drug interactions is mind numbing. Questioning the patient is no guarantee of accuracy. View the video to find out how Dominion Diagnostics met this challenge.

Good Day LA Interviews Dr. Bob Sears

submitted by: Sinupretforkids

Fox Morning News welcomes Pediatrician Doctor Bob Sears to discuss natural remedies. Renowned pediatrician Dr. Bob Sears has had excellent results with his patients using Bionorica's Sinupret for Kids.

Therapies for Multiple Sclerosis

submitted by: alex01

J. Kocsis, PhD. - The current approaches to the therapy of multiple sclerosis are reviewed by J. Kocsis (Yale University). His research emphasizes remyelination as an approach to the therapy of multiple sclerosis and spinal cord injury.

Alzheimer's Disease

submitted by: alex01
Z. Khachaturian, PhD. - New approaches to the therapy of Alzheimer’s disease (AD) are discussed in video interviews of this series. According to Z. Khachaturian (Potomac, MD) substantial progress has been made during the last 10 years in our understanding of pathogenesis of Alzheimer’s disease as well as in the discovery of biomarkers and therapeutic approaches. In addition to cholinergic drugs, inhibitors of plaque formation have been discovered, but the currently available...